These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38321884)

  • 21. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
    Callero MA; Suárez GV; Luzzani G; Itkin B; Nguyen B; Loaiza-Perez AI
    Int J Oncol; 2012 Jul; 41(1):125-34. PubMed ID: 22485252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
    Bai L; Yang JC; Ok JH; Mack PC; Kung HJ; Evans CP
    Int J Cancer; 2012 Jun; 130(11):2693-702. PubMed ID: 21792888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
    Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients.
    Fendler A; Bauer D; Busch J; Jung K; Wulf-Goldenberg A; Kunz S; Song K; Myszczyszyn A; Elezkurtaj S; Erguen B; Jung S; Chen W; Birchmeier W
    Nat Commun; 2020 Feb; 11(1):929. PubMed ID: 32066735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.
    Mizumoto A; Yamamoto K; Nakayama Y; Takara K; Nakagawa T; Hirano T; Hirai M
    J Pharmacol Exp Ther; 2015 Nov; 355(2):152-8. PubMed ID: 26306766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line.
    Ueda K; Ogasawara S; Akiba J; Nakayama M; Todoroki K; Ueda K; Sanada S; Suekane S; Noguchi M; Matsuoka K; Yano H
    PLoS One; 2013; 8(10):e75463. PubMed ID: 24116047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of SIRT2 in Regulation of Stemness of Cancer Stem-Like Cells in Renal Cell Carcinoma.
    Wei R; He D; Zhang X
    Cell Physiol Biochem; 2018; 49(6):2348-2357. PubMed ID: 30261494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymoquinone suppresses the proliferation of renal cell carcinoma cells via reactive oxygen species-induced apoptosis and reduces cell stemness.
    Liou YF; Chen PN; Chu SC; Kao SH; Chang YZ; Hsieh YS; Chang HR
    Environ Toxicol; 2019 Nov; 34(11):1208-1220. PubMed ID: 31298468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells.
    Chen YC; Zhang Z; Fouladdel S; Deol Y; Ingram PN; McDermott SP; Azizi E; Wicha MS; Yoon E
    Lab Chip; 2016 Aug; 16(15):2935-45. PubMed ID: 27381658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming sunitinib resistance with tocilizumab in renal cell carcinoma: Discordance between in vitro and in vivo effects.
    Kamli H; Owens EP; Vesey DA; Prasanna R; Li L; Gobe GC; Morais C
    Biochem Biophys Res Commun; 2022 Jan; 586():42-48. PubMed ID: 34826699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant phenotype of renal cell carcinoma cells is switched by ukrain administration in vitro.
    Gagliano N; Pettinari L; Aureli M; Martinelli C; Colombo E; Costa F; Carminati R; Volpari T; Colombo G; Milzani A; Dalle-Donne I; Gioia M
    Anticancer Drugs; 2011 Sep; 22(8):749-62. PubMed ID: 21799470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary supplement hymecromone and sorafenib: a novel combination for the control of renal cell carcinoma.
    Benitez A; Yates TJ; Shamaldevi N; Bowen T; Lokeshwar VB
    J Urol; 2013 Jul; 190(1):285-90. PubMed ID: 23228386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
    Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
    Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of Temsirolimus and tyrosine kinase inhibitors in renal carcinoma and endothelial cell lines.
    Martin B; Edeline J; Patard JJ; Oger E; Jouan F; Boulanger G; Zerrouki S; Vigneau C; Rioux-Leclercq N
    J Cancer Res Clin Oncol; 2012 Jun; 138(6):907-16. PubMed ID: 22322364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
    D'Costa NM; Lowerison MR; Raven PA; Tan Z; Roberts ME; Shrestha R; Urban MW; Monjaras-Avila CU; Oo HZ; Hurtado-Coll A; Chavez-Munoz C; So AI
    J Exp Clin Cancer Res; 2020 Feb; 39(1):33. PubMed ID: 32041631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting renal cell carcinoma with gambogic acid in combination with sunitinib in vitro and in vivo.
    Jiang XL; Zhang Y; Luo CL; Wu XH
    Asian Pac J Cancer Prev; 2012; 13(12):6463-8. PubMed ID: 23464475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
    Gao X; Jiang P; Zhang Q; Liu Q; Jiang S; Liu L; Guo M; Cheng Q; Zheng J; Yao H
    J Exp Clin Cancer Res; 2019 Aug; 38(1):362. PubMed ID: 31426831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair.
    Tan L; Huang Z; Chen Z; Chen S; Ye Y; Chen T; Chen Z
    J Chemother; 2023 Feb; 35(1):11-18. PubMed ID: 34927575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
    Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
    Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.
    Stewart GD; O'Mahony FC; Laird A; Rashid S; Martin SA; Eory L; Lubbock AL; Nanda J; O'Donnell M; Mackay A; Mullen P; McNeill SA; Riddick AC; Aitchison M; Berney D; Bex A; Overton IM; Harrison DJ; Powles T
    Eur Urol; 2014 Nov; 66(5):956-63. PubMed ID: 24821582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.